TERN vs TFC · $6.12B cap vs rev $24.54B
Terns Pharmaceuticals Inc (TERN) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
TFC (TFC) common stock.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
TERN currently screens at market cap $6.12B. TFC currently screens at market cap $0.
Not investment advice. Open the TERN and TFC stock pages for the full models.
Not investment advice.